Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 208 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Desc)]
Φίλτρα: Συντάκτης is Tziomalos, Konstantinos  [Clear All Filters]
2004
Karagiannis, A., Tziomalos K., Patsiaoura K., Nikolaidis N., Giouleme O., Mavroudis N., et al. (2004).  Focal nodular hyperplasia of the liver in a patient with primary aldosteronism.. J Gastroenterol Hepatol. 19(4), 480-1.
Karagiannis, A., Balaska K., Tziomalos K., Gerasimidis T., Karamanos D., Papayeoryiou A., et al. (2004).  Lack of an association between angiotensin converting enzyme gene polymorphism and peripheral arterial occlusive disease.. Vasc Med. 9(3), 189-92.
Karagiannis, A., Balaska K., Tziomalos K., Tokalaki-Nikolaidou L., Papayeoryiou A., & Zamboulis C. (2004).  Lack of an association between angiotensin-converting enzyme gene insertion/deletion polymorphism and ischaemic stroke.. Eur Neurol. 51(3), 148-52.
Karagiannis, A., Tziomalos K., Kakafika A., Harsoulis F., & Zamboulis C. (2004).  Paralysis as first manifestation of primary aldosteronism.. Nephrol Dial Transplant. 19(9), 2418-9.
Karagiannis, A., Tziomalos K., & Zamboulis C. (2004).  Plasma B-type natriuretic peptide is related to left ventricular mass in hypertensive patients.. Eur Heart J. 25(21), 1967.
Krikis, N., Tziomalos K., Perifanis V., Vakalopoulou S., Karagiannis A., Garypidou V., et al. (2004).  Treatment of recurrent gastrointestinal haemorrhage in a patient with von Willebrand's disease with administration of octreotide LAR and propranolol.. Hormones (Athens). 3(1), 65-7.
2005
Athyros, V. G., Mikhailidis D. P., Papageorgiou A. A., Didangelos T. P., Peletidou A., Kleta D., et al. (2005).  Targeting vascular risk in patients with metabolic syndrome but without diabetes.. Metabolism. 54(8), 1065-74.
Karagiannis, A., Tziomalos K., Krikis N., Sfikas G., Dona K., & Zamboulis C. (2005).  The unilateral measurement of blood pressure may mask the diagnosis or delay the effective treatment of hypertension.. Angiology. 56(5), 565-9.
2006
Karagiannis, A., Mathiopoulou L., Tziomalos K., Kontotasios K., Skaperdas A., Florentin M., et al. (2006).  Dry cough as first manifestation of giant-cell arteritis.. J Am Geriatr Soc. 54(12), 1957-8.
Athyros, V. G., Mikhailidis D. P., Didangelos T. P., Giouleme O. I., Liberopoulos E. N., Karagiannis A., et al. (2006).  Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study.. Curr Med Res Opin. 22(5), 873-83.
Karagiannis, A., Athyros V. G., Papageorgiou A., Tziomalos K., & Elisaf M. (2006).  Should atenolol still be recommended as first-line therapy for primary hypertension?. Hellenic J Cardiol. 47(5), 298-307.
2007
Karagiannis, A., Tziomalos K., & Athyros V. G. (2007).  Is angioedema a class adverse effect of the angiotensin-converting enzyme inhibitors?. Ann Allergy Asthma Immunol. 98(5), 502.
Athyros, V. G., Mikhailidis D. P., Kakafika A. I., Tziomalos K., & Karagiannis A. (2007).  Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?. Expert Opin Pharmacother. 8(5), 529-35.
Athyros, V. G., Liberopoulos E. N., Mikhailidis D. P., Papageorgiou A. A., Ganotakis E. S., Tziomalos K., et al. (2007).  Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, CHD, stroke, and peripheral arterial disease in a Mediterranean cohort.. Angiology. 58(6), 689-97.
Karagiannis, A., Mikhailidis D. P., Kakafika A. I., Tziomalos K., & Athyros V. G. (2007).  Atenolol: differences in mode of action compared with other antihypertensives. An opportunity to identify features that influence outcome?. Curr Pharm Des. 13(2), 229-39.
Athyros, V. G., Kakafika A. I., Papageorgiou A. A., Tziomalos K., Skaperdas A., Pagourelias E., et al. (2007).  Atorvastatin decreases triacylglycerol-associated risk of vascular events in coronary heart disease patients.. Lipids. 42(11), 999-1009.
Athyros, V. G., Tziomalos K., Mikhailidis D. P., Pagourelias E. D., Kakafika A. I., Skaperdas A., et al. (2007).  Do we need a statin-nicotinic acid-aspirin mini-polypill to treat combined hyperlipidaemia?. Expert Opin Pharmacother. 8(14), 2267-77.
Athyros, V. G., Mikhailidis D. P., Liberopoulos E. N., Kakafika A. I., Karagiannis A., Papageorgiou A. A., et al. (2007).  Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with CHD and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study.. Nephrol Dial Transplant. 22(1), 118-27.
Tziomalos, K., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2007).  Endothelial function, arterial stiffness and lipid lowering drugs.. Expert Opin Ther Targets. 11(9), 1143-60.
Karagiannis, A., Tziomalos K., Kakafika A., Florentin M., & Athyros V. Gabriel (2007).  Eplerenone relieves spironolactone-induced painful gynaecomastia in a patient with primary aldosteronism.. Nephrol Dial Transplant. 22(1), 293.
Athyros, V. G., Mikhailidis D. P., Kakafika A. I., Karagiannis A., Hatzitolios A., Tziomalos K., et al. (2007).  Identifying and attaining LDL-C goals: mission accomplished? Next target: new therapeutic options to raise HDL-C levels.. Curr Drug Targets. 8(3), 483-8.
Karagiannis, A., Mikhailidis D. P., Athyros V. G., Kakafika A. I., Tziomalos K., Liberopoulos E. N., et al. (2007).  The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?. Expert Opin Ther Targets. 11(2), 191-205.
Karagiannis, A., Mikhailidis D. P., Tziomalos K., Sileli M., Savvatianos S., Kakafika A., et al. (2007).  Serum uric acid as an independent predictor of early death after acute stroke.. Circ J. 71(7), 1120-7.
Athyros, V. G., Kakafika A. I., Papageorgiou A. A., Pagourelias E. D., Savvatianos S. D., Elisaf M., et al. (2007).  Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients.. Open Cardiovasc Med J. 1, 8-14.
2008
Athyros, V. G., Kakafika A. I., Tziomalos K., Karagiannis A., & Mikhailidis D. P. (2008).  Antisense technology for the prevention or the treatment of cardiovascular disease: the next blockbuster?. Expert Opin Investig Drugs. 17(7), 969-72.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές